Fig. 1From: Seven-year kinetics of RTS, S/AS01-induced anti-CSP antibodies in young Kenyan childrenStudy design showing the initial RTS,S/AS01 phase IIb clinical trial participants screening, randomization, and the longitudinal plasma samples collection from baseline month (M) M0. This was followed by the administration of 3 monthly doses of either RTS,S/AS01, or rabies vaccines at M0, M1, and M2. The second sample was collected one month after the final dose (M3) whilst the third sample was collected at M 6.5. The subsequent samples were collected annually up to M93Back to article page